From: Risk factors for the occurrence of visual-threatening posterior capsule opacification
Variables | Crude OR | Adjusted OR |
---|---|---|
Urbanization | ||
Urban | Reference | Reference |
Sub-urban | 0.93 (0.877–0.987) | 0.935 (0.881–0.992) |
Rural | 0.817 (0.757–0.881) | 0.821 (0.760–0.886) |
Low income | 0.807 (0.54–1.205) | 0.803 (0.536–1.202) |
Co-morbidities | ||
Keratopathy | 1.042 (0.955–1.137) | 0.988 (0.904–1.081) |
DED | 1.16 (1.066–1.262) | 1.114 (1.022–1.215) |
Glaucoma | 1.251 (1.154–1.357) | 1.222 (1.125–1.326) |
Uveitis | 1.281 (1.013–1.621) | 1.185 (0.933–1.505) |
AMD | 1.177 (1.051–1.319) | 1.147 (1.024–1.286) |
Hypertension | 0.988 (0.936–1.043) | 0.976 (0.92–1.034) |
DM | 0.933 (0.881–0.989) | 0.905 (0.85–0.963) |
Hyperlipidemia | 1.092 (1.03–1.158) | 1.107 (1.039–1.179) |
Congestive heart failure | 1.011 (0.921–1.109) | 1.024 (0.929–1.128) |
Myocardial infarction | 0.94 (0.77–1.148) | 0.927 (0.756–1.135) |
Cerebrovascular disease | 1.008 (0.935–1.086) | 1.02 (0.943–1.103) |
Peripheral vascular disease | 1.047 (0.929–1.179) | 1.035 (0.917–1.168) |
Dementia | 0.786 (0.654–0.944) | 0.762 (0.632–0.918) |
Chronic pulmonary disease | 1.032 (0.971–1.096) | 1.014 (0.953–1.079) |
Rheumatic disease | 1.027 (0.876–1.203) | 0.996 (0.849–1.168) |
Peptic ulcer disease | 1.158 (1.091–1.229) | 1.156 (1.087–1.229) |
Liver disease | 1.087 (1.015–1.164) | 1.067 (0.993–1.145) |
Hemiplegia or paraplegia | 0.839 (0.690–1.020) | 0.828 (0.679–1.009) |
Renal disease | 0.894 (0.812–0.985) | 0.876 (0.793–0.968) |
Malignancy | 0.996 (0.895–1.109) | 0.974 (0.874–1.085) |
Coagulation defects | 0.857 (0.436–1.686) | 0.883 (0.447–1.744) |